Cencora (0HF3.L)

Healthcare | Medical Distribution
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 80,663,532,000 75,453,673,000 81,487,060,000 79,050,106,000
Cost of Revenue 78,005,131,000 72,837,849,000 79,223,229,000 76,886,898,000
Gross Profit 2,658,401,000 2,615,824,000 2,263,830,999 2,163,208,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,672,881,000 1,600,040,000 1,472,055,000 1,490,343,000
Operating Expenses 1,672,881,000 1,600,040,000 1,472,055,000 1,490,343,000
Operating Income 985,520,000 1,015,784,000 791,776,000 672,865,000
Interest Expense 116,896,000 132,318,000 61,181,000 54,320,000
Income Before Tax 896,277,000 928,656,000 620,447,000 125,177,000
Income Tax Expense 206,528,000 211,239,000 126,728,000 117,711,000
Net Income 687,402,000 717,871,000 488,600,000 3,382,000
Per Share
EPS 3.55 3.70 2.52 0.02
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-09-30 2023-09-30 2022-09-30
Revenue 293,958,599,000 262,173,411,000 238,587,006,000
Cost of Revenue 285,257,361,000 253,213,918,000 230,986,369,000
Gross Profit 8,701,238,000 8,959,493,000 7,600,637,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 5,661,106,000 5,309,984,000 4,848,962,000
Operating Expenses 5,661,106,000 6,273,888,000 4,848,962,000
Operating Income 3,040,132,000 2,340,731,000 2,751,675,000
Interest Expense 248,682,000 228,931,000 231,982,000
Income Before Tax 2,003,975,000 2,160,836,000 2,183,057,000
Income Tax Expense 484,702,000 428,260,000 516,517,000
Net Income 1,509,120,000 1,745,293,000 1,698,820,000
Per Share
EPS 7.60 8.62 8.15
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-09-30 2023-09-30 2022-09-30
Assets
Cash and Cash Equivalents 3,132,648,000 2,592,051,000 3,533,169,000
Short Term Investments 0 0 0
Net Receivables 23,960,044,000 20,988,201,000 18,625,243,000
Inventory 18,998,833,000 17,454,768,000 17,088,455,000
Total Current Assets 47,717,813,000 42,798,826,000 39,589,758,000
Property Plant Equipment 2,181,410,000 2,135,171,000 3,079,977,000
Goodwill and Intangibles 13,319,073,000 23,580,017,000 12,836,623,000
Total Assets 67,101,667,000 62,558,746,000 56,560,616,000
Liabilities
Account Payables 50,942,162,000 45,836,037,000 40,192,890,000
Short Term Debt 576,331,000 641,344,000 1,070,473,000
Total Current Liabilities 54,277,053,000 48,831,198,000 43,477,955,000
Long Term Debt 3,811,745,000 5,070,360,000 4,632,360,000
Total Liabilities 66,314,925,000 61,892,459,000 56,489,343,000
Shareholders Equity
Retained Earnings 5,417,139,000 4,324,187,000 2,977,646,000
Total Shareholders Equity 645,938,000 666,287,000 -211,559,000
Balance Sheet (Annual) 2024-09-30 2023-09-30 2022-09-30
Assets
Cash and Cash Equivalents 3,132,648,000 2,592,051,000 3,533,169,000
Short Term Investments 0 0 0
Net Receivables 23,960,044,000 20,988,201,000 18,625,243,000
Inventory 18,998,833,000 17,454,768,000 17,088,455,000
Total Current Assets 47,717,813,000 42,798,826,000 39,589,758,000
Property Plant Equipment 2,181,410,000 2,135,171,000 3,079,977,000
Goodwill and Intangibles 13,319,073,000 23,580,017,000 12,836,623,000
Total Assets 67,101,667,000 62,558,746,000 56,560,616,000
Liabilities
Account Payables 50,942,162,000 45,836,037,000 40,192,890,000
Short Term Debt 576,331,000 641,344,000 1,070,473,000
Total Current Liabilities 54,277,053,000 48,831,198,000 43,477,955,000
Long Term Debt 3,811,745,000 5,070,360,000 4,632,360,000
Total Liabilities 66,314,925,000 61,892,459,000 56,489,343,000
Shareholders Equity
Retained Earnings 5,417,139,000 4,324,187,000 2,977,646,000
Total Shareholders Equity 645,938,000 666,287,000 -211,559,000
Cash Flow Statement (Quarterly) 2024-09-30 2023-09-30 2022-09-30
Operating Activities
Net Income 1,519,273,000 1,732,576,000 1,698,820,000
Depreciation & Amortization 1,118,842,000 963,904,000 697,943,000
Stock Based Compensation 147,998,000 124,624,000 93,400,000
Change in Working Capital 298,688,000 874,542,000 -139,662,000
Operating Cash Flow 3,484,685,000 3,911,334,000 2,703,088,000
Investing Activities
Capital Expenditure -487,173,000 -458,359,000 -496,318,000
Investments -487,173,000 -458,359,000 -496,318,000
Investing Cash Flow -618,096,000 -2,602,465,000 -368,437,000
Financing Activities
Debt Repayment -385,452,000 -623,258,000 -923,103,000
Common Stock Issued/Repurchased -1,453,527,000 -1,180,728,000 -389,792,000
Dividends Paid -416,168,000 -398,752,000 -391,687,000
Financing Cash Flow -2,330,994,000 -2,222,278,000 -1,752,780,000
Summary
Free Cash Flow 2,997,512,000 3,452,975,000 2,206,770,000
Net Change in Cash 541,471,000 -840,650,000 986,027,000
Cash Flow Statement (Annual) 2024-09-30 2023-09-30 2022-09-30
Operating Activities
Net Income 1,519,273,000 1,732,576,000 1,698,820,000
Depreciation & Amortization 1,118,842,000 963,904,000 697,943,000
Stock Based Compensation 147,998,000 124,624,000 93,400,000
Change in Working Capital 298,688,000 874,542,000 -139,662,000
Operating Cash Flow 3,484,685,000 3,911,334,000 2,703,088,000
Investing Activities
Capital Expenditure -487,173,000 -458,359,000 -496,318,000
Investments -487,173,000 -458,359,000 -496,318,000
Investing Cash Flow -618,096,000 -2,602,465,000 -368,437,000
Financing Activities
Debt Repayment -385,452,000 -623,258,000 -923,103,000
Common Stock Issued/Repurchased -1,453,527,000 -1,180,728,000 -389,792,000
Dividends Paid -416,168,000 -398,752,000 -391,687,000
Financing Cash Flow -2,330,994,000 -2,222,278,000 -1,752,780,000
Summary
Free Cash Flow 2,997,512,000 3,452,975,000 2,206,770,000
Net Change in Cash 541,471,000 -840,650,000 986,027,000